Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion type Assertion NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_head.
- NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion description "[KIT amplification was associated with KIT protein expression and with presence of PDGFRA and EGFR amplifications both at the time of the first glioma diagnosis and at tumor recurrence, and with VEGFR2 amplification at tumor recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_provenance.
- NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion evidence source_evidence_literature NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_provenance.
- NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion SIO_000772 17189383 NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_provenance.
- NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion wasDerivedFrom befree-2016 NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_provenance.
- NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_assertion wasGeneratedBy ECO_0000203 NP586051.RAs21HXxvtQGM9gI5Lm8X5g_C5PgYRKQbSH4J0WEYcc1A130_provenance.